802581-10-8Relevant articles and documents
A non-hallucinogenic psychedelic analogue with therapeutic potential
Cameron, Lindsay P.,Tombari, Robert J.,Lu, Ju,Pell, Alexander J.,Hurley, Zefan Q.,Ehinger, Yann,Vargas, Maxemiliano V.,McCarroll, Matthew N.,Taylor, Jack C.,Myers-Turnbull, Douglas,Liu, Taohui,Yaghoobi, Bianca,Laskowski, Lauren J.,Anderson, Emilie I.,Zhang, Guoliang,Viswanathan, Jayashri,Brown, Brandon M.,Tjia, Michelle,Dunlap, Lee E.,Rabow, Zachary T.,Fiehn, Oliver,Wulff, Heike,McCorvy, John D.,Lein, Pamela J.,Kokel, David,Ron, Dorit,Peters, Jamie,Zuo, Yi,Olson, David E.
, p. 474 - 479 (2020/12/13)
The psychedelic alkaloid ibogaine has anti-addictive properties in both humans and animals1. Unlike most medications for the treatment of substance use disorders, anecdotal reports suggest that ibogaine has the potential to treat addiction to v
AZEPINO-INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS
-
Paragraph 0215-0216; 0217, (2020/09/12)
The present invention provides azepino-indoles and other heterocycles and methods of using the compounds for treating brain disorders.